Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05615805 · ClinicalTrials.gov registry record · NA
The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 142
- Enrollment target
NCT05615805 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 142 participants.
The verdict
NCT05615805, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
Study Summary
This is the first randomized controlled trial looking into post-injection rinse volume of standard ophthalmic eyewash and its affect on patient comfort up to 72 hours after injections.
Interventions
- OTHER OSDI questionnaire
- OTHER SPEEDII questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2021-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05615805
The ClinicalTrials.gov registry entry for NCT05615805 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which OSDI questionnaire is the first listed.
NCT05615805 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05615805 about?
NCT05615805 is a clinical study titled "The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections". This is the first randomized controlled trial looking into post-injection rinse volume of standard ophthalmic eyewash and its affect on patient comfort up to 72 hours after injections.
What is the current status of trial NCT05615805?
This trial is currently completed. It is a NA study. The enrollment target is 142 participants. The study started on 2021-03-01. Estimated completion is 2021-10-01.
What interventions are being tested in trial NCT05615805?
The interventions under investigation include: OSDI questionnaire (OTHER), SPEEDII questionnaire (OTHER).
Who is sponsoring clinical trial NCT05615805?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.